Reuters logo
BRIEF-Inovio Pharma awarded $6.1 mln sub-grant through Wistar Institute to develop DNA-based monoclonal antibodies against Zika virus
December 1, 2016 / 2:30 PM / in a year

BRIEF-Inovio Pharma awarded $6.1 mln sub-grant through Wistar Institute to develop DNA-based monoclonal antibodies against Zika virus

Dec 1 (Reuters) - Inovio Pharmaceuticals Inc :

* Inovio Pharmaceuticals awarded $6.1 million sub-grant through Wistar institute to develop DNA-based monoclonal antibodies against Zika virus

* Inovio pharma - sub-grant to the Wistar institute from bill & Melinda Gates Foundation Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below